Evidence map›Paper›PMID 42004063›Full record

ArticleAmerican journal of cancer research2026

Rare

Xiaoyong Chen, Linlin Wang, Junyan Zou, Jihao Zhou, Yaying Zhou, Min Zuo, Lina Hu, Xiaoying Dong, Peng Ke, Junjie Hou

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoyong ChenDepartment of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University) Shenzhen 518020, Guangdong, China.
Linlin WangDepartment of Hematology, The First People's Hospital of Yancheng, Affiliated Hospital of Nanjing University Medical School, The Yancheng Clinical College of Xuzhou Medical University Yancheng 224000, Jiangsu, China.
Junyan ZouTianjin Union Precision Diagnosis Co., Ltd. Tianjin 301636, China.
Jihao ZhouDepartment of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University) Shenzhen 518020, Guangdong, China.
Yaying ZhouDepartment of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University) Shenzhen 518020, Guangdong, China.
Min ZuoDepartment of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University) Shenzhen 518020, Guangdong, China.
Lina HuDepartment of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University) Shenzhen 518020, Guangdong, China.
Xiaoying DongTianjin Union Precision Diagnosis Co., Ltd. Tianjin 301636, China.
Peng KeDepartment of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University) Shenzhen 518020, Guangdong, China.
Junjie HouDepartment of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University) Shenzhen 518020, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-lymphoblastic lymphoma (T-LBL) is an aggressive malignancy of T-lymphoid precursors, rarely co-occurring with consequent rearrangement of nucleoporin 98 (

Indexed as

gene fusionnucleoporin 98RNA sequencingset binding protein 1T-lymphoblastic lymphoma

Identifiers

PMID42004063
PMCPMC13090480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.